2020
DOI: 10.7326/acpj202010200-039
|View full text |Cite
|
Sign up to set email alerts
|

Treatment effect of aspirin for primary prevention does not differ according to baseline ASCVD risk

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1

Citation Types

0
1
0

Year Published

2021
2021
2021
2021

Publication Types

Select...
1

Relationship

0
1

Authors

Journals

citations
Cited by 1 publication
(1 citation statement)
references
References 0 publications
0
1
0
Order By: Relevance
“…Haley, S.P. et al reviewed 12 randomized controlled trials (RCTs) and found that aspirin was not dose-dependent on the incidence of bleeding or ASCVD events, indicating that the dose might not be critical (Haley and Chessman, 2020).…”
Section: Inadequate Dose Of Aspirinmentioning
confidence: 99%
“…Haley, S.P. et al reviewed 12 randomized controlled trials (RCTs) and found that aspirin was not dose-dependent on the incidence of bleeding or ASCVD events, indicating that the dose might not be critical (Haley and Chessman, 2020).…”
Section: Inadequate Dose Of Aspirinmentioning
confidence: 99%